Ardelyx | ARDX - Assets


Ardelyx reported $486.17M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Abbott USD 86.71B 2.53B Dec/2025
Amgen USD 90.59B 445M Dec/2025
Ardelyx USD 486.17M 19.4M Sep/2025
aTyr Pharma USD 106.65M 5.12M Sep/2025
Corcept Therapeutics USD 823.61M 21.88M Sep/2025
Curis USD 29.23M 10.09M Jun/2025
Sanofi EUR 126.81B 25.48B Dec/2025
TG Therapeutics USD 1.03B 322.41M Sep/2025
United Therapeutics USD 7.35B 556.9M Sep/2025
Xoma USD 263.15M 39.7M Sep/2025